Publicacions en què col·labora amb Marcos González Díaz (3)

2024

  1. Proteogenomics & Immunopeptidomics guided the molecular classification of Chronic Lymphocytic Leukemia for peptide based immunotherapy

    IX Congress of the Spanish Proteomics Society

2023

  1. IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

    Blood Advances

  2. Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution

    Cancers, Vol. 15, Núm. 3